
脂肪原/去甲缩宫素D/BVT-0283-M001/1 mg
商品编号:
BVT-0283-M001
品牌:
Adipogen Inc
市场价:
¥1800.00
美元价:
1080.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
ProductDetails | |
---|---|
Synonyms | Tuckolide;(4S,5S,8S,10R,E)-4,5,8-Trihydroxy-10-methyl-3,4,5,8,9,10-hexahydro-2H-oxecin-2-one |
ProductType | Chemical |
Properties | |
Formula | C10H16O5 |
MW | 216.2 |
CAS | 127393-89-9 |
Source/HostChemicals | IsolatedfromPenicilliumsp. |
PurityChemicals | ≥98%(HPLC) |
Appearance | Whitetooff-whitesolid. |
Solubility | SolubleinDMSO,methanoloracetone. |
Identity | Determinedby1H-NMR. |
Declaration | ManufacturedbyBioViotica. |
InChiKey | HWMMWMJBUOCCFZ-XYEXOTNWSA-N |
ShippingandHandling | |
Shipping | AMBIENT |
ShortTermStorage | +4°C |
LongTermStorage | -20°C |
Use/StABIlity | Stableforatleast1yearafterreceiptwhenstoredat-20°C. Afterreconstitutionprotectfromlightat-20°C. |
Documents | |
MSDS | ![]() |
ProductSpecificationSheet | |
Datasheet | ![]() |
- Hypolipidemic.
- Cholesterolbiosynthesisinhibitor.
ProductReferences
- ChemicalinvestigationofthemetabolitesfromtheCanADIantuckahoe,Polyporustuberaster:W.A.Ayer,etal.;J.Nat.Prod.55,649(1992)
- Secondarymetabolitesbychemicalscreening.8.Decarestrictines,anewfamilyofinhibitorsofcholesterolbiosynthesisfromPenicillium.I.Straindescription,fermentation,isolationandproperties:S.Grabley,etal.;J.Antibiot.(Tokyo)45,56(1992)
- Secondarymetabolitesbychemicalscreening.9.Decarestrictines,anewfamilyofinhibitorsofcholesterolbiosynthesisfromPenicillium.II.StructureelucidationofthedecarestrictinesAtoD:A.Göhrt,etal.;J.Antibiot.(Tokyo)45,66(1992)
- Anon-enzymaticreactioninthelatebiosynthesisofthedecarestrictinefamily:M.Mayer&R.Thiericke;J.Antibiot.(Tokyo)46,1372(1993)
- SynthesisofTuckolide,aNewCholesterolBiosynthesisInhibitor:M.B.Andrus&T.L.Shih;J.Org.Chem.61,8780(1996)
- AnefficienttotalsynthesisofdecarestrictineD:P.Gupta,etal.;Eur.J.Org.Chem.2008,1195(2008)
- Asymmetricsynthesisofallylsilanesbytheborylationoflithiatedcarbamates:formaltotalsynthesisof(-)-decarestrictineD:M.Binanzer,etal.;Angew.Chem.Int.Ed.49,4264(2010)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们